Recombinant Human IL33
Catalog No : IGX-RP629
412.43€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Recombinant Human IL33 | ||
---|---|---|---|
Catalog No | IGX-RP629 | ||
Supplier’s Catalog No | IGX-RP629 | ||
Supplier | ImuGeX | ||
Source antigen | E. coli | ||
Reactivity | Human | ||
Cross reactivity | |||
Applications | |||
Molecular weight | 18 |
Storage | -70°C | ||
---|---|---|---|
Other names | IL-33, Nuclear factor from high endothelial venules, Interleukin-1 family member 11, IL1F-11, C9orf26, NF-HEV<br/>Recombinant Human Interleukin-33 (IL33) | ||
Grade | Highly Purified | ||
Purity | >95% as determined by SDS-PAGE | ||
Form | Recombinant Interleukin-33 was lyophilized from 0.2 μm filtered 1.0 mg/mL in PBS buffer. | ||
Reactivity life | 6 months | ||
Note | For reserch purpose only | ||
Purity | >95% as determined by SDS-PAGE | ||
Description | IL-33, a member of the IL-1 family, signals via a heterodimeric receptor complex consisting of ST2 and IL-1R accessory protein and triggers the activation of NF-B and all three MAPKs: p38, ERK1/2, and JNK1/2 in mast cells. IL-33 is expressed in multiple tissues and by several cell types such as dermal fibroblasts and small airway epithelial and bronchial smooth muscle cells. IL-33 activated IL-1-like signaling responses in mast cells and enhanced IL-5 and IL-13 production from murine Th2-polarized splenocytes. Moreover, it was found that both human and murine mast cells when stimulated in vitro with IL- 33 produced a wide spectrum of cytokines and chemokines. In addition, IL-33 enhanced IL-4-driven Th2 cell responses and acted as a selective chemoattractant for Th2 cell recruitment. |
© 2020 Imugex All Rights Reserved